Buy 2 ASX shares for cutting-edge tech changing the world: expert

Wilson analyst picks a pair of stocks that are using amazing technologies to produce innovative solutions to global problems.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite the tyranny of distance from the rest of the world, or perhaps because of it, Australia has produced its fair share of innovations.

There are, in fact, companies listed on the ASX right now that are working on sophisticated, market-leading technologies that could one day improve the lives of many around the world.

This week Wilson Asset Management analysts identify two such ASX shares that they recommend as a buy: 

A woman looks internationally at a digital interface of the world.

Image source: Getty Images

Helping people heal from terrible injuries

ASX biotechnology shares have taken an absolute pummeling over the past 12 months.

But equities dealer Will Thompson is high on Aroa Biosurgery Ltd (ASX: ARX).

"Aroa develops, manufactures and distributes medical products," he said in a WAM video.

"Their product is, with the fear of oversimplifying it, just a really high-quality Band-Aid, which you'd use if you were in a bad motorcycle crash and you lost quite a bit of skin."

The concept itself is mature, but Aroa's product is different from incumbents as it is made organically.

"Next year there's a few regulation changes, which could really benefit it."

In a horrible year for its peers, the Aroa share price is actually 7% higher than where it started 2022. The ASX share has rocketed up an eye-popping 44% since the start of October.

According to Thompson, Aroa has already put some runs on the board.

"It recently posted some storing sales numbers and actually showed that there's some cash generation as well," he said.

"Next year's going to be a big year for them, so it's a buy."

Helping resist global warming

Because of the bearish nature of markets this year, new ASX listings were few and far between.

LGI Ltd (ASX: LGI), which floated in October, is a rare example of a 2022 debutant that isn't in the resources sector.

Thompson explained that LGI is a gas abatement provider.

"Where all your rubbish and landfill goes, they take the methane out of that area," he said.

"Methane's 26 times worse for the environment than carbon dioxide. They turn that into energy, which they supply back into the market."

Therefore the business takes in revenue from both power generation and carbon credits.

"They're doing some really interesting investments where they think they can probably increase profitability by putting a battery in the system. So that's where the capital's going."

The initial public offer saw IGL shares sold at $1.50 per share. The stock closed Thursday at $1.97.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »

Broker Notes

WiseTech shares are bouncing back. Is it time to buy?

Could there be more upside ahead?

Read more »

Miner looks excited as he holds a nugget of gold he has discovered.
Broker Notes

Up 53%: Why this surging ASX All Ords gold stock just earned a major broker upgrade

A top broker forecasts this fast-rising ASX gold stock could rocket another 199%.

Read more »